Prognostic value of myocardial injury biomarker in COVID-19: a systematic review and meta-analysis by Chen, S, Marcella, E, Tandiono, J, Heriyanto, R, Jonatan, C, Kurniawan, A

Get full text

172P Anlotinib as treatment for advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival and progression free survival by Susanto, B., Marcella, E., Chen, S., Heriyanto, R.S., Tandiono, J., Wijovi, F., Tancherla, A., Kurniawan, A.

Get full text

151P Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for advanced NSCLC with EGFR-positive mutation patients: A systematic review by Chen, S., Marcella, E., Susanto, B., Tandiono, J., Heriyanto, R.S., Wijovi, F., Tancherla, A., Kurniawan, A.

Get full text

114P Nivolumab plus ipilimumab as first-line treatment for patients with advanced non-small cell lung cancer: A systematic review by Tandiono, J., Chen, S., Marcella, E., Susanto, B., Heriyanto, R.S., Wijovi, F., Tancherla, A., Kurniawan, A.

Get full text

148P Neutrophil to lymphocyte ratio as a prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer treated with tyrosine kinase inhibitor: A systemati... by Heriyanto, R.S., Tandiono, J., Marcella, E., Susanto, B., Chen, S., Wijovi, F., Tancherla, A., Kurniawan, A.

Get full text

112P Atezolizumab as first-line therapy for patients with advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival by Marcella, E., Susanto, B., Chen, S., Tandiono, J., Tancherla, A., Heriyanto, R.S., Wijovi, F., Kurniawan, A.

Get full text

On the Development of Concave Surface Boundary Layer Flows by Winoto, S. H., Tandiono, Shah, D. A., Mitsudharmadi, H.

Get full text